190 related articles for article (PubMed ID: 10666192)
1. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
von Wasielewski R; Seth S; Franklin J; Fischer R; Hübner K; Hansmann ML; Diehl V; Georgii A
Blood; 2000 Feb; 95(4):1207-13. PubMed ID: 10666192
[TBL] [Abstract][Full Text] [Related]
2. Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease.
Axdorph U; Porwit-MacDonald A; Grimfors G; Björkholm M
Leuk Lymphoma; 2001; 42(5):1055-65. PubMed ID: 11697623
[TBL] [Abstract][Full Text] [Related]
3. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
4. Follicular dendritic cells have prognostic relevance in Hodgkin's disease.
Alavaikko MJ; Blanco G; Aine R; Lehtinen T; Fellbaum C; Taskinen PJ; Sarpola A; Hansmann ML
Am J Clin Pathol; 1994 Jun; 101(6):761-7. PubMed ID: 8209866
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
[TBL] [Abstract][Full Text] [Related]
6. Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Pappa VI; Norton AJ; Gupta RK; Wilson AM; Rohatiner AZ; Lister TA
Ann Oncol; 1995 Jul; 6(6):559-65. PubMed ID: 8573534
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
8. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients.
MacLennan KA; Bennett MH; Tu A; Hudson BV; Easterling MJ; Hudson GV; Jelliffe AM
Cancer; 1989 Oct; 64(8):1686-93. PubMed ID: 2790683
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic grading of nodular sclerosis Hodgkin's disease. Lack of prognostic significance in 254 surgically staged patients.
Hess JL; Bodis S; Pinkus G; Silver B; Mauch P
Cancer; 1994 Jul; 74(2):708-14. PubMed ID: 8033052
[TBL] [Abstract][Full Text] [Related]
10. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.
Björkholm M; Holm G; Mellstedt H; Johansson B; Askergren J; Söderberg G
Scand J Haematol; 1977 Nov; 19(5):487-95. PubMed ID: 594663
[TBL] [Abstract][Full Text] [Related]
12. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.
Shankar AG; Ashley S; Radford M; Barrett A; Wright D; Pinkerton CR
J Clin Oncol; 1997 Jul; 15(7):2622-30. PubMed ID: 9215833
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
[TBL] [Abstract][Full Text] [Related]
14. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
[TBL] [Abstract][Full Text] [Related]
16. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
17. Is classical Hodgkin's disease indeed a single entity?
Levy A; Armon Y; Gopas J; Ariad S; Prinsloo I; Shpilberg O; Kapelushnik J; Sacks M; Benharroch D
Leuk Lymphoma; 2002 Sep; 43(9):1813-8. PubMed ID: 12685837
[TBL] [Abstract][Full Text] [Related]
18. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease.
Oudejans JJ; Jiwa NM; Kummer JA; Ossenkoppele GJ; van Heerde P; Baars JW; Kluin PM; Kluin-Nelemans JC; van Diest PJ; Middeldorp JM; Meijer CJ
Blood; 1997 Feb; 89(4):1376-82. PubMed ID: 9028961
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
20. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
